CSBR:NASDAQ
Champions Oncology Inc
4,59 USD
arrow_downward
−1,89%(−0,088) 1 D
17. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,70 USD
Høy
4,70 USD
Lav
4,59 USD
Markedsverdi
63,91 mill.
Snittvolum
7,80k
Volum
4,85k
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,70 USD
Høy
4,70 USD
Lav
4,59 USD
Markedsverdi
63,91 mill.
Snittvolum
7,80k
Volum
4,85k
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
BigGo Finance
·
for 14 minutter siden
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
TV News Check
·
for 45 minutter siden
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
marketscreener.com
·
for 1 time siden
S&P 500 Pullback Extends to Fourth Day Ahead of Nvidia's Earnings
www.tmgm.com
·
for 10 minutter siden
NSA outage sends Dow Jones Industrial Average lower before Nvidia beats
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com